195 related articles for article (PubMed ID: 36260098)
1. Differences in Insulin Sensitivity, Secretion, and the Metabolic Clearance Rate of Glucose in Newly Diagnosed Type 2 Diabetes Mellitus Patients: The Influences of Body Mass Index and Fatty Liver.
Xie Y; Li S; Chen R; He R; Qian L; Zou J; Luo Y; Zhang Y; Ji M; Liu Y
Metab Syndr Relat Disord; 2022 Oct; 20(8):451-458. PubMed ID: 36260098
[No Abstract] [Full Text] [Related]
2. [Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.].
Li FP; Zhang SQ; Wang F; Huang YQ; Fu ZZ; Yan L
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):940-3. PubMed ID: 20079327
[TBL] [Abstract][Full Text] [Related]
3. Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver disease.
Petralli G; Salvati A; Tricò D; Ricco G; Colombatto P; Brunetto MR; Solini A
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3736. PubMed ID: 37839068
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
5. Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.
Gignac T; Trépanier G; Pradeau M; Morissette A; Agrinier AL; Larose É; Marois J; Pilon G; Gagnon C; Vohl MC; Marette A; Carreau AM
Am J Physiol Endocrinol Metab; 2024 May; 326(5):E616-E625. PubMed ID: 38477665
[TBL] [Abstract][Full Text] [Related]
6. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
[TBL] [Abstract][Full Text] [Related]
9. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
10. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
[TBL] [Abstract][Full Text] [Related]
11. The Mediterranean Diet: Effects on Insulin Resistance and Secretion in Individuals with Overweight or Obesity.
Vetrani C; Verde L; Colao A; Barrea L; Muscogiuri G
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960178
[TBL] [Abstract][Full Text] [Related]
12. [Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].
Wang LY; Wei L; Yu HY; Zhang Y; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):235-8. PubMed ID: 19552838
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes.
Vadini F; Simeone PG; Desideri G; Liani R; Tripaldi R; Ciotti S; Tartaro A; Guagnano MT; Di Castelnuovo A; Cipollone F; Consoli A; Santilli F
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2685-2692. PubMed ID: 34226120
[TBL] [Abstract][Full Text] [Related]
14. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
[TBL] [Abstract][Full Text] [Related]
15. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone.
Chai SY; Pan XY; Song KX; Huang YY; Li F; Cheng XY; Qu S
Lipids Health Dis; 2014 Jan; 13():7. PubMed ID: 24397589
[TBL] [Abstract][Full Text] [Related]
16. INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE.
Nosko NO; Kharchenko VV
Wiad Lek; 2021; 74(10 cz 2):2593-2598. PubMed ID: 34923463
[TBL] [Abstract][Full Text] [Related]
17. Different Analysis of
Duan Y; Sun X; Liu J; Fu J; Wang G
J Diabetes Res; 2019; 2019():6053604. PubMed ID: 31772943
[TBL] [Abstract][Full Text] [Related]
18. Comparison of β-cell dysfunction and insulin resistance correlating obesity with type 2 diabetes: A cross-sectional study.
Liu J; Wang Y; Hu Y; Leng S; Wang G
J Diabetes Complications; 2016 Jul; 30(5):898-902. PubMed ID: 27012460
[TBL] [Abstract][Full Text] [Related]
19. Overweight, obesity, and their associations with insulin resistance and β-cell function among Chinese: a cross-sectional study in China.
Chen G; Liu C; Yao J; Jiang Q; Chen N; Huang H; Liang J; Li L; Lin L
Metabolism; 2010 Dec; 59(12):1823-32. PubMed ID: 20655552
[TBL] [Abstract][Full Text] [Related]
20. ANALYSIS THE METABOLIC STATUS OF PATIENTS WITH CORONARY ARTERY DISEASE AND NONALCOHOLIC FATTY LIVER DISEASE DEPENDING ON BODY MASS INDEX.
Maksymets T; Sorochka-Sirko M; Bondarenko O; Karpyshyn N; Bochar O; Bochar V; Sklyarov E
Wiad Lek; 2023; 76(1):41-45. PubMed ID: 36883488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
